Exelixis Patent Company LLC;Bristol-Myers Squibb Company
发明人:
申请号：
EP10721902.4
公开号：
EP2435410B1
申请日:
2010.05.26
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
Compounds, pharmaceutically acceptable salts, isomers, or prodrugs thereof, of the invention are disclosed, which are useful as modulators of the activity of liver X receptors (LXR). Pharmaceutical compositions containing the compounds and methods of using the compounds are also disclosed.
